Deferred Income Tax Expense (Benefit) in USD of Elevance Health, Inc. from Q1 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Elevance Health, Inc. quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from Q1 2010 to Q1 2025.
  • Elevance Health, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2025 was -$174M, a 228% decline year-over-year.
  • Elevance Health, Inc. annual Deferred Income Tax Expense (Benefit) for 2024 was -$374M, a 37.9% increase from 2023.
  • Elevance Health, Inc. annual Deferred Income Tax Expense (Benefit) for 2023 was -$602M, a 423% decline from 2022.
  • Elevance Health, Inc. annual Deferred Income Tax Expense (Benefit) for 2022 was -$115M, a 134% decline from 2021.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Growth (%)

Elevance Health, Inc. Quarterly Deferred Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 -$174M -$310M -228% Jan 1, 2025 Mar 31, 2025 10-Q 2025-04-22
Q1 2024 $136M +$391M Jan 1, 2024 Mar 31, 2024 10-Q 2025-04-22
Q1 2023 -$255M -$159M -166% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-18
Q1 2022 -$96M -$127M -410% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-19
Q1 2021 $31M -$26M -45.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-20
Q1 2020 $57M +$2M +3.64% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-21
Q1 2019 $55M +$106M Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-29
Q1 2018 -$51M +$106M +67.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-24
Q1 2017 -$157M -$231M -314% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-25
Q1 2016 $73.3M +$2.7M +3.82% Jan 1, 2016 Mar 31, 2016 10-Q 2017-04-26
Q1 2015 $70.6M -$14.6M -17.1% Jan 1, 2015 Mar 31, 2015 10-Q 2016-04-27
Q1 2014 $85.2M +$76.1M +836% Jan 1, 2014 Mar 31, 2014 10-Q 2015-04-29
Q1 2013 $9.1M -$50.8M -84.8% Jan 1, 2013 Mar 31, 2013 10-Q 2014-04-30
Q1 2012 $59.9M +$15.2M +34% Jan 1, 2012 Mar 31, 2012 10-Q 2013-04-24
Q1 2011 $44.7M +$4.5M +11.2% Jan 1, 2011 Mar 31, 2011 10-Q 2012-04-25
Q1 2010 $40.2M Jan 1, 2010 Mar 31, 2010 10-Q 2011-04-27

Elevance Health, Inc. Annual Deferred Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$374M +$228M +37.9% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-20
2023 -$602M -$487M -423% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-20
2022 -$115M -$457M -134% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-20
2021 $342M +$882M Jan 1, 2021 Dec 31, 2021 10-K 2024-02-21
2020 -$540M -$621M -767% Jan 1, 2020 Dec 31, 2020 10-Q 2023-10-18
2019 $81M -$10M -11% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-16
2018 $91M +$1.36B Jan 1, 2018 Dec 31, 2018 10-K 2021-02-18
2017 -$1.27B -$1.4B -1102% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-19
2016 $127M +$193M Jan 1, 2016 Dec 31, 2016 10-K 2019-02-20
2015 -$65.9M -$96.6M -315% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-21
2014 $30.7M -$28.4M -48.1% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-22
2013 $59.1M -$68.4M -53.6% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-19
2012 $128M +$53.2M +71.6% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-24
2011 $74.3M -$27.5M -27% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-20
2010 $102M Jan 1, 2010 Dec 31, 2010 10-K 2013-02-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.